Levothyroxine
Levothyroxine
CLINICAL USE
Hypothyroidism
DOSE IN NORMAL RENAL FUNCTION
25–300 micrograms daily depending on thyroid hormone levels
PHARMACOKINETICS
Molecular weight                           :798.9 %Protein binding                           :99.97 %Excreted unchanged in urine     : 30–55 Volume of distribution (L/kg)       :8.7–9.7half-life – normal/ESRD (hrs)      :6–7 days/ Unchanged DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal functionHDF/high flux   :Not dialysed. Dose as in normal renal functionCAV/VVHD      :Not dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants: effect of coumarins and phenindione enhanced ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
Uraemic toxins may result in inhibition of the enzyme associated with conversion of L-thyroxine to liothyronine
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home